Tag Archives: type 2 diabetes

Featured Stories

Oklahoma Woman Latest to Head to Court Over Alleged DePuy ASR Hip Implant Injuries

Lawsuits filed by alleged victims of DePuy Orthopaedics’ recalled ASR hip replacement devices continue to pile up in the multidistrict litigation currently underway in U.S. District Court, Northern District of Ohio. Most recently, a woman from Pryor, Oklahoma, filed suit alleging complications caused by a DePuy ASR hip implant ...

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

E-cigarettes Could Increase Risk of Lung Infections

E-cigarettes Could Increase Risk of Lung Infections

New research suggests the liquid used in electronic cigarettes could increase the risk of viral lung infections, regardless of whether it contains nicotine.

Read More

Louisiana Whistleblower Lawsuit Revived

Louisiana Whistleblower Lawsuit Revived

A state appeals court in Louisiana has ruled that a former employee of Rapides Parish Coliseum can proceed with a whistleblower lawsuit against the Coliseum Authority.

Read More

1,000+ Australians Join DePuy ASR Hip Implant Class Action Lawsuit

A class action lawsuit filed in Australia over DePuy Orthopaedics’ recalled metal-on-metal ASR Hip Implants has signed up more than 1,000 plaintiffs. The attorneys representing the Australian ASR Hip Implant lawsuit plaintiffs recently told The Courier-Mail that damages in the lawsuit are expected to be worth more than $200 million. One ...

Read More

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a woman who suffered injuries after receiving transvaginal mesh implants. The lawsuit suit alleges that the transvaginal mesh created an unreasonable risk and directly caused her injuries.

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

J.J. Fuds, Inc. Pet Food Recalled - Listeria Contamination

J.J. Fuds, Inc. Pet Food Recalled Over Potential Listeria Contamination

J.J. Fuds, has recalled a specific lot of its J.J. Fuds Chicken Tender Chunks Pet Food over potential contamination with the dangerous, Listeria monocytogenes pathogen.

Read More

New York Man Claims Biomet Metal-on-Metal Hip Implant Caused Pain, Disability

A New York man claims his metal-on-metal hip implant was defective and required replacement within a year of receiving it. This has left him facing a lifetime of pain, disability, and rising medical costs.

Read More

Invokana’s Link to Ketoacidosis Allegedly Hidden by Janssen and J&J

Invokana’s Link to Ketoacidosis Hidden by Janssen and J&J

A Florida woman alleges, in a recent lawsuit brought against the makers of Invokana–Janssen Pharmaceuticals, and its parent company Johnson & Johnson (J&J)–, that the drug makers neglected to issue a proper warning about the connection between Invokana and ketoacidosis, … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , , , , , , , , |

Janssen Failed to Warn of Ketoacidosis Risk with Invokana Diabetes Drug, Suit Alleges

Janssen Failed to Warn of Issue with Invokana Diabetes Drug

Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, is accused of failing to warn about the risk of ketoacidosis with its type 2 diabetes drug Invokana. Diabetic ketoacidosis is a serious condition caused by the build up of ketone bodies, … Continue reading

Posted in Pharmaceuticals | Tagged , , , , , , , , |

FDA Warns Newer Type 2 Diabetes Drugs May Cause Ketoacidosis

FDA Warns Newer Type 2 Diabetes Drugs May Cause Ketoacidosis

The Food and Drug Administration (FDA) is warning that some of the newer Type 2 diabetes medicines—canagliflozin (Invokana), dapagliflozin (Farxiga), and empagliflozin (Jardiance)—may cause ketoacidosis, a serious condition where the body produces high levels of blood acids called ketones. Patients … Continue reading

Posted in Health Concerns, Pharmaceuticals | Tagged , , , , |

Study Shows Increased Risk of Type 2 Diabetes for Statin Users

Increased Risk of Type 2 Diabetes for Statin Users

A new study from Finland has confirmed previous findings about a link between the use of cholesterol-lowering statin drugs and higher risk of Type 2 diabetes. This study, published in the journal Diabetologia, avoided some of the limitations of earlier … Continue reading

Posted in Health Concerns, Pharmaceuticals, Zocor | Tagged , , , |

Financial ties between researchers, drug companies taint clinical data

Much of the so-called clinical data gathered to approve new prescription drugs or used to back marketing claims a company wishes to make about its products is likely soiled by financial ties between the person who wrote the research and … Continue reading

Posted in Avandia, Legal News, Pharmaceuticals | Tagged , , |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.